Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Fetal Pediatr Pathol ; 36(3): 232-239, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28368675

ABSTRACT

INTRODUCTION: The aim of our study was to determine lipid peroxidation products and antioxidant enzyme activity in umbilical cord blood of small for gestational age (SGA) neonates. MATERIALS AND METHODS: Umbilical cord arterial blood samples were collected from 21-term singleton SGA newborn infants and 21 age- and sex-matched appropriate for gestational age (AGA) term neonates prospectively born by elective cesarean section for determination of malondialdehyde (MDA) as a marker of lipid peroxidation and superoxide dismutase (SOD) for antioxidant activity. RESULTS: MDA levels were increased (5.20 vs. 3.52 nmol/mL; p < 0.001), while levels of SOD (6.24 vs. 8.99 U/mL; p < 0.01) were decreased in SGA neonates when compared with AGA newborn infants. CONCLUSIONS: Elevated MDA levels and decreased SOD activity in umbilical cord blood may show the possibility of insufficient protective mechanisms against increased oxidative stress in SGA neonates born by cesarean section.


Subject(s)
Biomarkers/blood , Cesarean Section/adverse effects , Infant, Small for Gestational Age/blood , Oxidative Stress , Adult , Case-Control Studies , Female , Fetal Blood/metabolism , Humans , Infant, Newborn , Lipid Peroxidation , Male , Malondialdehyde/blood , Pregnancy , Prospective Studies , Superoxide Dismutase/blood , Term Birth
2.
J Turk Ger Gynecol Assoc ; 16(3): 174-8, 2015.
Article in English | MEDLINE | ID: mdl-26401112

ABSTRACT

OBJECTIVE: This study was conducted to compare the tocolytic efficacy of glyceryltrinitrate (GTN) with that of magnesium sulfate (MgSO4) and to investigate serum nitric oxide metabolites before and after tocolysis. MATERIAL AND METHODS: In total, 48 women between 27 and 34 weeks' gestation with threatened preterm labor and intact membranes were randomly allocated to receive either GTN or MgSO4 tocolysis. Main outcome measures included tocolytic efficacy and maternal side effect(s) of the tocolytic agent. Obstetric and neonatal outcomes as well as pretreatment and posttreatment nitric oxide (NO) metabolites were assessed. RESULTS: Forty-one patients were included into the final analysis. Uterine contraction cessation times were 3.66±1.28 and 6.83±3.47 hours for GTN and MgSO4 groups, respectively. Similarly, maternal side effects were significantly lower in the GTN group than in the MgSO4 group, and no serious maternal side effects were recorded. Serum NO metabolite levels before treatment were significantly lower in the treatment groups than in the controls. Serum nitrite levels were significantly increased after tocolytic treatment both in MgSO4 and GTN groups. CONCLUSION: GTN effectively delays preterm delivery and reduces neonatal morbidity and mortality with less maternal side effects and seems to be an effective and safe alternative to MgSO4.

3.
Eur J Obstet Gynecol Reprod Biol ; 180: 12-5, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24997423

ABSTRACT

INTRODUCTION: In this study, we aimed to investigate the relationship between neutrophil-to-lymphocyte ratio (NLR) and total bile acid (TBA) concentration in pregnant women with intrahepatic cholestasis of pregnancy (ICP). MATERIALS AND METHODS: Fasting and postprandial TBA, NLR, and aminotransferase (AST/ALT) levels in the blood samples of 65 pregnant women with intrahepatic cholestasis were examined in this prospective case-control study. Thirty-three of the patients had mild disease and 32 had severe disease; 70 healthy women in uncomplicated pregnancies served as the control group. RESULTS: Not only was the mean NLR elevated in the pregnant women with cholestasis when compared to the controls, but it also predicted the severity of the cholestasis. The correlation between fasting TBA and NLR was significant. COMMENTS: Although TBA is still the diagnostic standard, NLR can be used as an initial screening tool due to its high specificity.


Subject(s)
Bile Acids and Salts/blood , Cholestasis, Intrahepatic/blood , Neutrophils , Pregnancy Complications/blood , Adult , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Biomarkers/blood , Case-Control Studies , Cholestasis, Intrahepatic/diagnosis , Female , Humans , Leukocyte Count , Lymphocyte Count , Pregnancy , Pregnancy Complications/diagnosis , Prospective Studies , Sensitivity and Specificity , Young Adult
4.
Arch Med Sci ; 10(2): 396-400, 2014 May 12.
Article in English | MEDLINE | ID: mdl-24904678

ABSTRACT

INTRODUCTION: The aim of this study was to evaluate the efficacy of Hypericum perforatum for prevention of adhesion formation in rats. MATERIAL AND METHODS: Twenty-four female wistar rats underwent left uterine horn adhesion model. Rats were randomised into 4 groups. Group 1 (Control): Closure of abdominal incision without any agent administration. Group 2: Closure of incision after administration of intraperitoneal (i.p.) Ringer's lactate solution. Group 3: Closure of incision after administration of i.p. olive oil (diluent of H. perforatum). Group 4: Hypericum perforatum extract (Ecodab(®)) was administered i.p. before the closure of incision. Fourteen days later, relaparatomy was performed and surgical adhesion scores, inflammation and fibrosis scores were noted. Groups were compared according to these scores. RESULTS: There was statistical significant difference between ringer's lactate group and olive oil group according to surgical adhesion score (p = 0.009). However, groups were not different according to inflammation and fibrosis scores (p > 0.05). CONCLUSIONS: Despite antiinflammatory, antioxidants and antimicrobial properties of H. perforatum, our results revealed no positive effect of H. perforatum on the prevention of intraperitoneal adhesion formation.

5.
Arch Gynecol Obstet ; 287(3): 511-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23086134

ABSTRACT

PURPOSE: The aim of this study is to evaluate the efficacy and the tolerability of three classic antimuscarinic drugs used in the treatment of over active bladder syndrome using clinical data and quality of life tests, and to evaluate the parameters affecting the success of these drugs. METHODS: A total of 90 patients with urge urinary incontinence were randomly allocated into three groups either to receive tolterodine (group A), trospium chloride (group B) or oxybutynin (group C). Urogenital distress inventory short form (UDI-6) and Incontinence impact questionnaire short form (IIQ-7) of the Turkish Urogynecology and Pelvic Reconstructive Surgery Association were performed to each patient before and after treatment to evaluate the effectiveness and tolerability of the antimuscarinic drugs. Adverse events were also recorded during treatment. RESULTS: Improved urodynamic test values were recorded after 6 weeks of treatment in each group. Similarly, statistically significant differences were observed in UDI-6 and IIQ-7 test scores before and after treatment. Complete cure was achieved in 86 % of patients in group A; however, complete cure rates were 67 and 80 % in group B and C, respectively. Although, patients reported comparable tolerability against trospium chloride (77 %) and tolterodine (80 %), only 23 % of patients using oxybutynin considered the drug as tolerable. The most common side effect was dry mouth, followed by insomnia. Both dry mouth and insomnia was highest in group C (50 %). One patient (0.3 %) in group B and two patients (0.7 %) in group C reported that they did not want to continue to use the drug. CONCLUSION: Antimuscarinic medications are very successful in the treatment of urge urinary incontinence; however, the success of treatment is not only limited to clinical improvement. Patients do not regard a drug as successful unless it is tolerable, easy to adapt to the daily life and improve the quality of life even it has very successful clinical outcomes.


Subject(s)
Benzhydryl Compounds/therapeutic use , Benzilates/therapeutic use , Cresols/therapeutic use , Mandelic Acids/therapeutic use , Muscarinic Antagonists/therapeutic use , Nortropanes/therapeutic use , Phenylpropanolamine/therapeutic use , Urinary Bladder, Overactive/drug therapy , Urinary Incontinence, Urge/drug therapy , Adult , Female , Humans , Middle Aged , Quality of Life , Tolterodine Tartrate , Treatment Outcome , Urinary Bladder, Overactive/complications , Urinary Incontinence, Urge/etiology , Urodynamics/drug effects
6.
J Matern Fetal Neonatal Med ; 24(10): 1259-61, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21504338

ABSTRACT

OBJECTIVE: The aim of this study was to demonstrate the neuroprotective effect of magnesium sulfate on ischemia-reperfusion-induced injury in fetal rat brain. METHODS: Twenty-four, 19-days pregnant rats were randomly allocated into four groups. Fetal brain ischemia was induced by clamping the utero-ovarian artery bilaterally for 20 min and reperfusion was achieved by removing the clamps for 30 min. The control group consisted of noninjured rats. No treatment was given in the ischemia-reperfusion group; whereas 1 ml saline and 600 mg/kg magnesium sulfate was administered in the vehicle and the treatment groups 30 min before ischemia reperfusion injury. Lipid peroxidation in the brain tissue was determined as the concentration of thiobarbituric acid-reactive substances (TBARS) for each fetal rat. A one-way analysis of variance and post hoc test were used for statistical analysis. RESULTS: TBARS levels were found to be increased after ischemia reperfusion injury when compared with controls. Magnesium sulfate treatment prevented the increase in TBARS after ischemia reperfusion injury. CONCLUSIONS: We have shown that magnesium sulfate decreases TBARS levels significantly in fetal rat brain subjected to ischemia reperfusion injury and may have potential therapeutic benefits by reducing oxidative stress after intrauterine ischemia-reperfusion-induced fetal brain damage.


Subject(s)
Anticonvulsants/therapeutic use , Brain Injuries/prevention & control , Fetal Diseases/prevention & control , Magnesium Sulfate/therapeutic use , Reperfusion Injury/prevention & control , Animals , Brain Injuries/etiology , Brain Ischemia/complications , Drug Evaluation, Preclinical , Female , Pregnancy , Rats , Rats, Wistar
7.
Arch Gynecol Obstet ; 283(5): 1005-9, 2011 May.
Article in English | MEDLINE | ID: mdl-20499074

ABSTRACT

PURPOSE: The aim of this study was to evaluate the association between nonreassuring fetal heart rate patterns during labor and umbilical cord nucleated red blood cell counts. METHODS: Nucleated red blood cell data was collected prospectively from 41 singleton term neonates presented with nonreassuring fetal heart rate patterns and/or meconium stained amniotic fluid during labor (study group) and from 45 term neonates without any evidence of nonreassuring fetal status (controls). Umbilical artery pH, blood gases and base excess were also determined to investigate the correlation between independent variables. RESULTS: The median nucleated red blood cells per 100 white blood cells were 13 (range 0-37) in the study group and 8 (range 0-21) in the control group. Stepwise regression analysis have identified meconium stained amniotic fluid (R(2) = 0.15, p < 0.0001) and umbilical artery PO(2) (R(2) = 0.1, p = 0.002) as independent variables associated with elevated NRBC counts in patients with nonreassuring fetal heart rate patterns. CONCLUSIONS: Nucleated red blood cells in the cord blood of newborns were found to be elevated in patients with nonreassuring FHR patterns during labor. However, the wide range and the poor correlation of NRBC count with umbilical artery pH and blood gas values limit its clinical utility as a marker for fetal hypoxia.


Subject(s)
Erythroblasts , Fetal Blood/cytology , Fetal Distress/blood , Heart Rate, Fetal , Adolescent , Adult , Blood Cell Count , Case-Control Studies , Female , Fetal Diseases/blood , Fetal Diseases/physiopathology , Humans , Hypoxia/blood , Hypoxia/physiopathology , Infant, Newborn , Pregnancy , Term Birth , Young Adult
8.
J Clin Ultrasound ; 38(6): 325-7, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20544870

ABSTRACT

We report a case of ovarian cystic teratoma with an important growth during pregnancy and the sonographic appearance of intracystic multiple, mobile, polygonal structures called intracystic "fat balls." Due to the rapid growth of the lesion, which exceeded 15 cm in diameter, a right oophorectomy was performed. Histopathologic diagnosis confirmed the mature cystic teratoma. The presence of floating balls composed of keratin and fat is rarely seen but is pathognomonic of mature cystic teratomas. Growth of a teratoma during pregnancy is a rare condition.


Subject(s)
Adipose Tissue/diagnostic imaging , Ovarian Neoplasms/diagnostic imaging , Teratoma/diagnostic imaging , Adipose Tissue/surgery , Adolescent , Female , Follow-Up Studies , Humans , Ovarian Neoplasms/surgery , Ovary/diagnostic imaging , Ovary/surgery , Pregnancy , Teratoma/surgery , Ultrasonography
9.
J Matern Fetal Neonatal Med ; 23(6): 569-72, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19672792

ABSTRACT

We report three maternal deaths which might be in possible association with the use of intravaginal dinoprostone for cervical ripening and induction of labor. All cases occurred at our institution between January 2006 and December 2007. Uterine atony and profuse bleeding followed by disseminated intravascular coagulation (DIC), characterized by severe hypofibrinogenemia developed shortly after delivery of the first two patients. The third patient developed respiratory symptoms in the active labor followed by hemodynamic changes manifested by tetanic uterine contractions and fetal heart rate decelerations. Cardiac arrest developed in all patients shortly after the occurrence of symptoms with no response to any medical intervention. The pharmacologic induction of labor with dinoprostone may be in association with increased risk of maternal death because of increased risk of postpartum DIC and amnionic fluid embolism. Further investigations seem to be needed.


Subject(s)
Dinoprostone/adverse effects , Labor, Induced/mortality , Labor, Induced/methods , Mothers , Administration, Intravaginal , Adult , Death , Dinoprostone/administration & dosage , Female , Humans , Labor, Induced/adverse effects , Oxytocics/administration & dosage , Oxytocics/adverse effects , Pregnancy
10.
Arch Gynecol Obstet ; 282(6): 613-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-19856183

ABSTRACT

INTRODUCTION: Patients with history of gestational diabetes (GDM) are at high risk for developing diabetes mellitus (DM) after pregnancy. This study investigates the rate of GDM patients who received screening and the prevalence of DM in the early post-partum period. MATERIALS AND METHODS: This study included 78 patients diagnosed and treated for GDM between January 2005 and December 2007. They were evaluated whether or not they were screened with 75 g oral glucose tolerance test (OGTT) or fasting blood glucose measurement at post-partum 6-12-week period. The rates of DM and impaired glucose tolerance (IGT) were determined. RESULTS: Of 78 GDM patients only 10 (12.8%) patients were screened with OGTT and 27 (34.6%) patients were screened with fasting blood glucose (FBG) measurement. 41 (52.6%) patients did not receive any post-partum screening. Insulin treated patients during pregnancy underwent OGTT more frequently (p = 0.008). We found that 61% of the patients who did not receive any screening test were seen by a doctor for any reason during this period. DM was diagnosed in 50% of patients who underwent OGTT and 7.4% of patients who underwent FBG measurement during early post-partum period (p = 0.013). CONCLUSION: Despite the fact that GDM is generally strictly and carefully monitored during pregnancy, it is usually neglected in the post-partum period. Insulin treated patients during pregnancy should be informed better for post-partum screening with OGTT. OGTT appears to be a better way of screening to diagnose DM.


Subject(s)
Diabetes Mellitus/diagnosis , Mass Screening/statistics & numerical data , Postpartum Period , Adult , Diabetes, Gestational , Female , Glucose Tolerance Test/statistics & numerical data , Humans , Pregnancy , Retrospective Studies
11.
Eur J Obstet Gynecol Reprod Biol ; 124(1): 27-31, 2006 Jan 01.
Article in English | MEDLINE | ID: mdl-15950366

ABSTRACT

OBJECTIVE: The aim of our study was to evaluate lipid peroxidation products and antioxidant enzyme activity in placental tissue and umbilical cord blood, as a marker for fetal hypoxia in patients in labor with nonreassuring fetal status. STUDY DESIGN: Umbilical cord arterial blood and placental tissue samples were collected from 24 patients with term pregnancies in labor and nonreassuring fetal heart rate (FHR) patterns (study) and 24 women with normal pregnancies in labor and normal FHR tracings (controls) for determination of malondialdehyde (MDA) as a marker for lipid peroxidation and superoxide dismutase (SOD) for the antioxidant activity. Measured values were compared statistically between two groups using independent samples t-test or Mann-Whitney U-test. RESULTS: The median 1min Apgar score was 8 (range 4-9) in the study group and 9 (range 8-10) in the control group, respectively (p < 0.001). There was no statistically significant difference between study and control groups in terms of mean 5 min Apgar scores (p > 0.05). Placental MDA levels in patients with nonreassuring fetal status were found to be significantly elevated compared to the control group (12.14 nmol/g tissue versus 9.75 nmol/g tissue; p < 0.01). The placental SOD activity in the study group was significantly higher (p < 0.01) compared to controls (3.57 U/mg protein versus 2.63 U/mg protein). The umbilical cord blood MDA levels in the study group were higher than in normal pregnancies (4.99 nmol/mL, 3.88 nmol/mL; p < 0.05). The activity of SOD in umbilical cord blood was significantly higher (p < 0.001) in patients with nonreassuring fetal status when compared with the control group (11.62 versus 6.95 U/mL). CONCLUSION: Lipid peroxidation products and antioxidant functions were elevated in the umbilical cord blood and placenta of patients having nonreassuring FHR tracings during labor. These findings indicate that lipid peroxidation products in placenta and umbilical cord blood can be used as a possible marker for fetal hypoxia during labor and SOD levels may discriminate acute from chronic hypoxia. Further investigations are needed with large number of series to clarify the variations of lipid peroxidation and antioxidant activity due to acute or chronic fetal hypoxia.


Subject(s)
Fetal Distress/physiopathology , Labor, Obstetric/blood , Lipid Peroxidation , Superoxide Dismutase/blood , Adult , Antioxidants/analysis , Cesarean Section , Delivery, Obstetric , Female , Fetal Blood/chemistry , Fetal Distress/blood , Heart Rate, Fetal , Humans , Malondialdehyde/blood , Placenta/chemistry , Pregnancy
12.
Aust N Z J Obstet Gynaecol ; 45(2): 159-60, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15760321

ABSTRACT

This study of 30 patients evaluated the effectiveness and safety of the posterior sling (infracoccygeal sacropexy) in the surgical treatment of vaginal vault prolapse. The patients were reevaluated 3 months, 6 months and yearly postoperatively. Coexisting preoperative symptoms of pelvic pain, urgency, nocturia and 'obstructed' micturition feeling were followed-up. There was remarkable improvement in vault prolapse and in coexisting symptoms.


Subject(s)
Gynecologic Surgical Procedures/methods , Uterine Prolapse/surgery , Aged , Female , Humans , Middle Aged , Treatment Outcome
13.
Gynecol Obstet Invest ; 57(3): 139-43, 2004.
Article in English | MEDLINE | ID: mdl-14707473

ABSTRACT

The efficacy and safety of misoprostol for cervical ripening and labor induction in patients with oligohydramnios was investigated. 57 pregnancies with oligohydramnios and 58 cases with a normal amniotic fluid volume (controls) were enrolled in this prospective trial. All patients received 50 microg of intravaginal misoprostol every 5 h. Primary outcomes were: cesarean section rate; induction to delivery time; oxytocin augmentation; uterine hyperstimulation; meconium passage; fetal heart rate (FHR) changes; fetal distress requiring delivery, and Apgar scores. There were no differences in the mean time to delivery, cesarean section rate, oxytocin augmentation or Apgar scores. The mean induction to delivery time in oligohydramnios and control groups were, 11 h 43 min and 11 h 18 min, respectively (p > 0.05). FHR changes were observed in 26.3% of oligohydramnios group and 32.7% of control group (p > 0.05). There was no statistically significant difference in the cesarean section rate and the uterine hyperstimulation between the 2 groups. These data suggest that misoprostol can be used as an effective agent for cervical ripening and labor induction in pregnancies with oligohydramnios without increasing the risk for perinatal outcome, compared to those with normal amniotic fluid volumes.


Subject(s)
Cervical Ripening/drug effects , Labor, Induced/methods , Misoprostol/therapeutic use , Oligohydramnios , Oxytocics/therapeutic use , Administration, Intravaginal , Adult , Apgar Score , Cesarean Section/statistics & numerical data , Female , Fetal Distress/epidemiology , Gestational Age , Heart Rate, Fetal , Humans , Misoprostol/adverse effects , Oxytocin/administration & dosage , Pregnancy , Prospective Studies , Risk Factors , Time Factors
14.
J Reprod Med ; 47(2): 164-6, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11883356

ABSTRACT

BACKGROUND: Hydatid disease in pregnancy is a rare condition, with an incidence of 1/20,000 pregnancies. Although the female reproductive system is a rare site for hydatid disease, various obstetric and gynecologic presentations have been reported. CASE: A 31-year-old multipara was evaluated due to obstructed labor. Sonographic evaluation revealed an 18-cm hepatic and 15-cm pelvic hydatid cyst at 38 weeks of gestation. A healthy, 3,200-g infant was delivered by cesarean section. The cyst, originating in the right ovary and occupying the pouch of Douglas, was removed surgically. The hepatic cyst was decompressed via the percutaneous approach. The follow-up was uneventful. CONCLUSION: Hydatid disease should be considered in the differential diagnosis of adnexal masses in pregnancy. The percutaneous technique is a promising treatment option for hepatic cysts. Not only the diagnosis but also the treatment of hydatid disease is facilitated with currently available magnetic resonance imaging, computed tomography and ultrasonography.


Subject(s)
Echinococcosis, Hepatic/complications , Echinococcosis/complications , Obstetric Labor Complications/etiology , Pelvis , Pregnancy Complications, Parasitic/surgery , Adult , Cesarean Section , Disease Progression , Echinococcosis/surgery , Echinococcosis, Hepatic/surgery , Female , Humans , Obstetric Labor Complications/surgery , Pelvis/surgery , Pregnancy , Pregnancy Outcome , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...